(NASDAQ:GNLX), WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development, effective July 1, 2025. “We are delighted to welcome Eric to the executive team,” said Thomas […]

(CNSX:LCR.CN),(OTC US:LANRF),(Other OTC:LANRF),(Boerse Frankfurt – Freiverkehr:6UF0), VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) — Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster“, the “Company“) is pleased to announce the completion of its acquisition of 100% of the Lake Cargelligo Gold Project, a district-scale exploration property in the famed Cobar mining district of New South

HIGH RIVER, Alberta, July 07, 2025 (GLOBE NEWSWIRE) — Western Financial Group is proud to announce it has been named a recipient of the 2025 Canadian Business Excellence Award for Private Businesses, presented by Excellence Canada. This national recognition celebrates organizations that demonstrate outstanding customer experience, employee engagement, and innovation. “This award is a reflection

(NasdaqGM:NRIX), SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to bexobrutideg (NX-5948) for the treatment of lymphoplasmacytic lymphoma. Bexobrutideg is

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2025 program at Boumadine in the Kingdom of Morocco. Today's results also extend the Imariren mineralized trend to 1 kilometer (“km”)

(TSX-V:IVS), TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce final assays from grade-control drilling of the 10,000-tonne Trench 1 Bulk Sample Site on its 100%-owned Pardo Gold Project, located 65 km northeast of Sudbury, Ontario. Highlights Assay results from grade-control drilling at the

(TSX:BLX), MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) — Boralex Inc. (TSX: BLX) (“Boralex” or the “Company”) announces the closing of an additional corporate financing of $250 million by way of an unsecured subordinated loan with a term of 8 years. The investment is made by La Caisse (formerly CDPQ), which is providing an amount of

Completion of enrollment achieved nearly one year ahead of schedule Primary analysis anticipated two years post-treatment TOKYO and LONDON and BOSTON, July 07, 2025 (GLOBE NEWSWIRE) — Orchard Therapeutics, a Kyowa Kirin company, today announced the last patient has been treated in a registrational trial evaluating the efficacy and safety of OTL-203, an investigational hematopoietic

(NASDAQ:UNCY), LOS ALTOS, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 4th Annual Kidney Virtual Conference on

CORRECTION – Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services GlobeNewswire July 07, 2025 CHICAGO, July 07, 2025 (GLOBE NEWSWIRE) — In a release issued under the